Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway

Epithelial to mesenchymal transition (EMT) occurs during development and cancer progression to metastasis and results in enhanced cell motility and invasion. Transforming growth factor-β (TGF-β) induces EMT through Smads, leading to transcriptional regulation, and through non-Smad pathways. We observe that TGF-β induces increased cell size and protein content during EMT. This translational regulation results from activation by TGF-β of mammalian target of rapamycin (mTOR) through phosphatidylinositol 3-kinase and Akt, leading to the phosphorylation of S6 kinase 1 and eukaryotic initiation factor 4E–binding protein 1, which are direct regulators of translation initiation. Rapamycin, a specific inhibitor of mTOR complex 1, inhibits the TGF-β–induced translation pathway and increase in cell size without affecting the EMT phenotype. Additionally, rapamycin decreases the migratory and invasive behavior of cells that accompany TGF-β–induced EMT. The TGF-β–induced translation pathway through mTOR complements the transcription pathway through Smads. Activation of mTOR by TGF-β, which leads to increased cell size and invasion, adds to the role of TGF-β–induced EMT in cancer progression and may represent a therapeutic opportunity for rapamycin analogues in cancer.

[1]  M. Zafarullah,et al.  Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in human chondrocytes. , 2007, Cellular signalling.

[2]  J. Blenis,et al.  Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways , 2006, Oncogene.

[3]  Jacob D. Jaffe,et al.  mSin1 Is Necessary for Akt/PKB Phosphorylation, and Its Isoforms Define Three Distinct mTORC2s , 2006, Current Biology.

[4]  N. Hynes,et al.  The mTOR Pathway in Breast Cancer , 2006, Journal of Mammary Gland Biology and Neoplasia.

[5]  G. Kroemer,et al.  Current development of mTOR inhibitors as anticancer agents , 2006, Nature Reviews Drug Discovery.

[6]  C. Heldin,et al.  Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition , 2006, The Journal of cell biology.

[7]  P. Smolewski.  Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway , 2006, Anti-cancer drugs.

[8]  O. Meyuhas,et al.  Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. , 2006, Trends in biochemical sciences.

[9]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[10]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[11]  C. Arteaga.  Inhibition of TGFβ signaling in cancer therapy , 2006 .

[12]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[13]  Huan Yang,et al.  Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer. , 2005, Current opinion in investigational drugs.

[14]  G. Baffet,et al.  Involvement of the serine/threonine p70S6 kinase in TGF-beta1-induced ADAM12 expression in cultured human hepatic stellate cells. , 2005, Journal of hepatology.

[15]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[16]  Jiri Zavadil,et al.  TGF-β and epithelial-to-mesenchymal transitions , 2005, Oncogene.

[17]  C. Heldin,et al.  Non-Smad TGF-β signals , 2005, Journal of Cell Science.

[18]  David M Sabatini,et al.  An expanding role for mTOR in cancer. , 2005, Trends in molecular medicine.

[19]  Jae Youn Yi,et al.  Type I Transforming Growth Factor β Receptor Binds to and Activates Phosphatidylinositol 3-Kinase* , 2005, Journal of Biological Chemistry.

[20]  Yue Zhang,et al.  Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity , 2005, Science.

[21]  Florian Grebien,et al.  Cell Size Control: New Evidence for a General Mechanism , 2005, Cell cycle.

[22]  R. Selgas,et al.  Effects of Rapamycin on the Epithelial-to-mesenchymal Transition of Human Peritoneal Mesothelial Cells , 2005, The International journal of artificial organs.

[23]  C. Brigati,et al.  The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes. , 2004 .

[24]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[25]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[26]  D. Shegogue,et al.  Mammalian Target of Rapamycin Positively Regulates Collagen Type I Production via a Phosphatidylinositol 3-Kinase-independent Pathway* , 2004, Journal of Biological Chemistry.

[27]  J. Blenis,et al.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.

[28]  A. Grimberg.  Mechanisms by which IGF-I May Promote Cancer , 2003, Cancer biology & therapy.

[29]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[30]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[31]  L. Cantley,et al.  United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. , 2003, Biochemical Society transactions.

[32]  P. Pandolfi,et al.  Does the ribosome translate cancer? , 2003, Nature Reviews Cancer.

[33]  Allan Balmain,et al.  TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.

[34]  J. Zavadil,et al.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  H. Moses,et al.  Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.

[36]  M. Reiss.  TGF- and cancer , 1999 .

[37]  W. Wood,et al.  A BMP homolog acts as a dose-dependent regulator of body size and male tail patterning in Caenorhabditis elegans. , 1999, Development.

[38]  R. W. Padgett,et al.  Specificity of TGFbeta signaling is conferred by distinct type I receptors and their associated SMAD proteins in Caenorhabditis elegans. , 1999, Development.

[39]  P. LuValle,et al.  A BMP responsive transcriptional region in the chicken type X collagen gene. , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  L. de Ridder,et al.  In vitro and in vivo models for the study of brain tumour invasion. , 1997, Anticancer research.

[41]  T. Sullivan,et al.  Rapid chondrocyte maturation by serum‐free culture with BMP‐2 and ascorbic acid , 1997, Journal of cellular biochemistry.

[42]  F. McCormick,et al.  Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. , 1997, Science.

[43]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[44]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Derynck,et al.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.

[46]  D. Fingar,et al.  Transforming growth factor-beta induces airway smooth muscle hypertrophy. , 2006, American journal of respiratory cell and molecular biology.

[47]  H. Moses,et al.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. , 2001, Molecular biology of the cell.

[48]  M. Tremblay,et al.  Roles of protein tyrosine phosphatases in cell migration and adhesion. , 1999, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[49]  T. Brand,et al.  The TGFβ superfamily in myocardium: Ligands, receptors, transduction, and function , 1995 .